Compare PRME & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRME | VLRS |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | United States | Mexico |
| Employees | N/A | 7098 |
| Industry | Medicinal Chemicals and Botanical Products | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.4M | 923.4M |
| IPO Year | 2022 | N/A |
| Metric | PRME | VLRS |
|---|---|---|
| Price | $3.43 | $9.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | $7.56 | ★ $9.16 |
| AVG Volume (30 Days) | ★ 2.9M | 600.4K |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,632,000.00 | N/A |
| Revenue This Year | $7.06 | $13.96 |
| Revenue Next Year | $47.01 | $12.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 55.28 | N/A |
| 52 Week Low | $2.28 | $4.40 |
| 52 Week High | $6.94 | $10.80 |
| Indicator | PRME | VLRS |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 70.77 |
| Support Level | $3.16 | $8.59 |
| Resistance Level | $3.68 | $9.81 |
| Average True Range (ATR) | 0.25 | 0.43 |
| MACD | 0.04 | 0.14 |
| Stochastic Oscillator | 65.56 | 84.72 |
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).